TH
Trung Huynh UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
54.5%
Neutral
45.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $25 |
942%
upside
| 3 | -24% |
0
%
| 15 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $140 |
14%
downside
| 4 | +24% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $895 |
7%
upside
| 2 | +5.4% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $317 |
9%
upside
| 3 | – |
–
| 6 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $584 |
3%
upside
| 4 | – |
–
| 11 Jul ‘25 3 months ago |
|
|
|
Buy
Maintained
| $38 |
42%
upside
| 2 | +12% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $25 |
1%
upside
| 2 | – |
–
| 30 Apr ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $54 |
23%
upside
| 1 | – |
–
| 11 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $7 |
202%
upside
| 1 | +67% |
0
%
| 1 Apr ‘25 6 months ago |
|